or Try an Advanced Search...

    ETF Components for MJ - ETFMG Alternative Harvest ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    TLRY F 3.10 7.74
    SNDL F 2.81 6.85
    IIPR F 2.12 6.82
    REFI A 0.50 3.39
    HITI C 2.64 2.52
    AFCG D -0.21 2.16
    OGI F 3.38 1.40
    GRWG F 6.46 1.28
    MAPS B -3.81 1.12
    TPB A 1.11 0.97
    JAZZ B 2.99 0.80
    MO A 0.46 0.78
    PM A 1.07 0.75
    SMG C 0.94 0.65

    Represented by ETF Holdings

    Keywords: Cannabis Medicinal Plants Medicine Cigar Cigarette Entheogens Euphoriants Health Sciences Herbalism Medical Cannabis Real Estate Investment Trust Tobacco Tobacco Products Cannabis Products Cannabis Smoking Carcinogens Dipping Tobacco Drugs Loan Plants
    Industries: Drug Manufacturers - Specialty & Generic Tobacco Agricultural Inputs Biotechnology Conglomerates Home Improvement Retail Pharmaceutical Retailers REIT - Industrial REIT - Mortgage REIT - Specialty

    Recent News for ETFMG Alternative Harvest ETF & its Holdings

    Date Stock Title
    Nov 21 SMG ScottsMiracle-Gro 2024 Corporate Responsibility Report: Giving Waste New Life
    Nov 21 MO Top Dividend Stock Altria Is Currently Trading In A Buy Zone
    Nov 21 TLRY Redhook Brewery and Montlake Futures Team Up to Launch Montlake Gameday Gold Lager, a New Craft Beer in Support of University of Washington Athletes
    Nov 21 TLRY Tilray Brands Unveils 2024 Holiday Cannabis Gift Guide
    Nov 21 JAZZ Zymeworks, Jazz Pharmaceuticals Receive FDA's Accelerated Approval for Ziihera to Treat Biliary Tract Cancer
    Nov 21 TLRY Tilray Brands Gets Festive with its 2024 Holiday Beverage Gift Guide
    Nov 21 JAZZ Jazz and Zymeworks announce FDA approval of cancer therapy Ziihera
    Nov 21 PM Mohamed El-Erian Warns Against Simplistic Narratives As Trump Plans Aggressive Tariff Strategy: 'The Issue Is Quite Complex'
    Nov 21 JAZZ Jazz Pharmaceuticals Announces U.S. FDA Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC)
    Nov 20 SMG Is The Scotts Miracle-Gro Company (SMG) the Best Fertilizer Stock to Buy?
    Nov 20 TLRY Tilray Brands, Inc. (TLRY) Stock Moves -1.53%: What You Should Know
    Nov 20 TLRY Prediction: Tilray Brands Won't Be a Cannabis Company in 5 Years
    Nov 20 SMG Scotts Miracle-Gro: Mixed Execution And Limited Future Debt Reduction Cap Upside (Downgrade)
    Nov 20 IIPR 3 Dividend Stocks On US Exchanges Offering Up To 7.3% Yield
    Nov 20 TLRY Exploring ACNB And 2 More Undervalued Small Caps With Insider Buying In US
    Nov 20 TLRY Beverages, Alcohol and Tobacco Stocks Q3 Recap: Benchmarking Tilray Brands (NASDAQ:TLRY)
    Nov 19 JAZZ Jazz Pharmaceuticals to Participate in Citi's 2024 Global Healthcare Conference
    Nov 19 MO Altria Group: Market Share Woes Continue To Undermine This Value Prospect
    Nov 19 JAZZ Should Value Investors Buy Jazz Pharmaceuticals (JAZZ) Stock?
    Nov 19 JAZZ Silver Ring Value Partners: Jazz Pharmaceuticals (JAZZ) Is a “High Uncertainty With Low Risk” Investment
    MJ tracks the Prime Alternative Harvest Index, designed to measure the performance of companies within the cannabis ecosystem benefitting from global medicinal and recreational cannabis legalization initiatives. First U.S. and world’s largest ETF to target the global cannabis industry. Many other significant applications for cannabis and THC based medicines and treatments ranging from epilepsy to cancer treatment to non-opioid pain management. The global cannabis market is expected to grow at a CAGR of around 17% and reach $55.8 billion by 2025.¹
    Medicine Cancer Pain Cancer Treatment Cannabis Euphoriants Opioids Entheogens Pain Management Medicinal Plants Epilepsy Herbalism Medical Cannabis
    Back to the Main MJ Page...